Clinical Trial: Effectiveness of E-prf Alone and in Combination With Bioactive Glass Nanoparticles in Grade II Furcation Defects

U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07042204) titled 'Effectiveness of E-prf Alone and in Combination With Bioactive Glass Nanoparticles in Grade II Furcation Defects' on June 18.

Brief Summary: The aim of the study is to evaluate and compare the effectiveness of extended platelet-rich fibrin (ePRF) alone and in combination with bioactive glass nanoparticles in the treatment of grade II furcation defects clinically and radiographically.

Study Start Date: Jan. 03, 2024

Study Type: INTERVENTIONAL

Condition: Furcation Defects

Intervention: PROCEDURE: Group I (extended platelet-rich fibrin)

mucoperiosteal flap will be raised through sulcular incisions Debridement of granulation tiss...